iShares Biotechnology ETF
787 hedge funds and large institutions have $4.61B invested in iShares Biotechnology ETF in 2025 Q3 according to their latest regulatory filings, with 84 funds opening new positions, 156 increasing their positions, 317 reducing their positions, and 63 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
14% less funds holding in top 10
Funds holding in top 10: 7 → 6 (-1)
27% less call options, than puts
Call options by funds: $184M | Put options by funds: $253M
51% less repeat investments, than reductions
Existing positions increased: 156 | Existing positions reduced: 317
Holders
787
Holding in Top 10
6
Calls
$184M
Puts
$253M
Top Buyers
| 1 | +$210M | |
| 2 | +$65.1M | |
| 3 | +$40.4M | |
| 4 |
JP Morgan Chase
New York
|
+$32.8M |
| 5 |
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
|
+$21.7M |
Top Sellers
| 1 | -$71.3M | |
| 2 | -$54.3M | |
| 3 | -$51M | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$35.1M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$16M |
